🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

136+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 16 of 136 recruiting trials for “progeroid-features-hepatocellular-carcinoma-predisposition-syndrome”

Phase 2RecruitingNCT04134559 ↗

Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma

👨‍⚕️ Allison O'Neill, MD, Dana-Farber Cancer Institute📍 5 sites📅 Started Nov 2020View details ↗
Phase 2RecruitingNCT04770207 ↗

Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs

👨‍⚕️ Zhenfeng Zhang, MD, PhD, Second Affiliated Hospital of Guangzhou Medical University📍 1 site📅 Started Nov 2020View details ↗
NARecruitingNCT06487663 ↗

TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant Tumors

🏥 Tianjin Medical University Cancer Institute and Hospital📍 1 site📅 Started Oct 2020View details ↗
RecruitingNCT04390724 ↗

Optimizing Y90 Therapy for Radiation Lobectomy

👨‍⚕️ Robert Lewandowski, MD, Northwestern University📍 2 sites📅 Started Jul 2020View details ↗
RecruitingNCT05520788 ↗

Ambispective Cohort Study of Precision Medicine for Primary Hepatobiliary Cancer Based on Next-generation Sequencing

👨‍⚕️ Wanguang Zhang, Tongji Hospital📍 1 site📅 Started May 2020View details ↗
Phase 1RecruitingNCT04248569 ↗

DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma

👨‍⚕️ Mark Yarchoan, MD, Johns Hopkins Medical Institution📍 1 site📅 Started Apr 2020View details ↗
RecruitingNCT04525833 ↗

Liver Disease and Other Systemic Diseases

👨‍⚕️ Ching-Sheng Hsu, Ph.D, Liver Diseases Research Center, Taipei Tzu Chi Hospital📍 1 site📅 Started Jan 2020View details ↗
Phase 1, PHASE2RecruitingNCT03942328 ↗

Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer

👨‍⚕️ Lewis R. Roberts, MD, PhD, Mayo Clinic in Rochester📍 1 site📅 Started Sep 2019View details ↗
RecruitingNCT03894917 ↗

Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

👨‍⚕️ Sukeshi Patel Arora, MD, Mays Cancer Center📍 1 site📅 Started Sep 2019View details ↗
NARecruitingNCT07305428 ↗

Downstaging Unresectable Hepatocellular Carcinoma to Resectable Disease With Combined Immunotherapy and Stereotactic Beamed Radiotherapy: a Pilot Study

🏥 The University of Hong Kong📍 1 site📅 Started Apr 2019View details ↗
NARecruitingNCT03823144 ↗

Intravital Microscopy in Human Solid Tumors

👨‍⚕️ Emmanuel M Gabriel, M.D., Ph.D., Mayo Clinic📍 1 site📅 Started Feb 2019View details ↗
RecruitingNCT05276037 ↗

Value of Negative 18FDG PET/CT in Milan Out, Up-to-seven in, HCC Transplant Candidates

🏥 University of Liege📍 6 sites📅 Started Jan 2019View details ↗
RecruitingNCT03612726 ↗

The Overall Survival of Patients With Unresectable HCC in Real-life

👨‍⚕️ Masao Omata, PhD, MD, Tokyo University📍 3 sites📅 Started Jul 2018View details ↗
Enrolling by InvitationNCT07042841 ↗

AI-Driven Quantitative Decision and Surgical Planning System for Liver Cancer

👨‍⚕️ Shuo Jin, PhD, Beijing Tsinghua Chang Gung Hospital📍 1 site📅 Started Jun 2015View details ↗
RecruitingNCT03959800 ↗

Molecular Basis of Pediatric Liver Cancer

🏥 University of Pittsburgh📍 1 site📅 Started Jun 2015View details ↗
Enrolling by InvitationNCT03308773 ↗

Disease Prevention in Clinical Practice Base on Patient Specific Physiology

👨‍⚕️ John P Armato, MD, Providence St Josephs Health📅 Started Jan 2009View details ↗
← PreviousPage 7 of 7

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →